Literature DB >> 4856046

A biochemical mechanism for the delayed cytotoxic reaction of 6-mercaptopurine.

D M Tidd, A R Paterson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4856046

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  54 in total

Review 1.  The clinical pharmacology of 6-mercaptopurine.

Authors:  L Lennard
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

2.  A phase II trial of continuous-infusion 6-mercaptopurine for childhood solid tumors.

Authors:  P C Adamson; S Zimm; A H Ragab; S M Steinberg; F Balis; B A Kamen; T J Vietti; A Gillespie; D G Poplack
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

3.  DNA synthesis as a therapeutic target: the first 65 years.

Authors:  Christopher K Mathews
Journal:  FASEB J       Date:  2012-06       Impact factor: 5.191

4.  Cranial irradiation and cerebrospinal fluid levels of 6-mercaptopurine in children with acute leukemia.

Authors:  R Riccardi; A Lasorella; R L Tartaglia; A Riccardi; T Servidei; R Mastrangelo
Journal:  Med Oncol Tumor Pharmacother       Date:  1991

Review 5.  The use of therapeutic drug monitoring to optimise immunosuppressive therapy.

Authors:  S M Tsunoda; F T Aweeka
Journal:  Clin Pharmacokinet       Date:  1996-02       Impact factor: 6.447

6.  6-Thioguanine: high-dose 2-H infusions in goats.

Authors:  T J Schouten; R A De Abreu; E D Schretlen; M B van Leeuwen; J M van Baal; G A de Vaan
Journal:  J Cancer Res Clin Oncol       Date:  1985       Impact factor: 4.553

7.  Intracellular pharmacodynamic studies of the synergistic combination of 6-mercaptopurine and cytosine arabinoside in human leukemia cell lines.

Authors:  L V Ramilo-Torno; V I Avramis
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

8.  Childhood leukaemia: a relationship between intracellular 6-mercaptopurine metabolites and neutropenia.

Authors:  L Lennard; C A Rees; J S Lilleyman; J L Maddocks
Journal:  Br J Clin Pharmacol       Date:  1983-10       Impact factor: 4.335

9.  Clinical significance of azathioprine active metabolite concentrations in inflammatory bowel disease.

Authors:  S Wright; D S Sanders; A J Lobo; L Lennard
Journal:  Gut       Date:  2004-08       Impact factor: 23.059

10.  Molecular dynamics simulation of a human thiopurine S-methyltransferase complexed with 6-mercaptopurine model.

Authors:  Wanwimon Mokmak; Sissades Tongsima; Ekachai Jenwitheesuk
Journal:  Bioinformation       Date:  2009-09-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.